Article
Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.
Drug metabolism and disposition: the biological fate of chemicals - 1 Sept 2012
Fedejko-Kap Barbara, Bratton Stacie M, Finel Moshe, Radominska-Pandya Anna, Mazerska Zofia
Abstract excerpt
5-Diethylaminoethylamino-8-hydroxyimidazoacridinone, C-1311 (NSC-645809), is an antitumor agent shown to be effective against breast cancer in phase II clinical trials. A similar compound, 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone, C-1305, shows high activity against experimental tumors and is expected to have even more beneficial pharmacological properties than C-1311. Previously published studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.